Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuro Kumeda

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Clinical Calcium|August 3, 2006
[Bone metabolic abnormality in diabetes: especially about osteoblast dysfunction]Yasuro Kumeda
Clinical Calcium|May 1, 2008
[Osteoporosis in diabetes]Yasuro Kumeda
Clinical Calcium|November 8, 2005
[Metabolic syndrome and magnesium]Yasuro Kumeda, Masaaki Inaba
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 1, 2002
[Diabetic osteoporosis]Yasuro Kumeda, Masaaki Inaba
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 16, 2020
Efficacy and Safety of Tofogliflozin and Ipragliflozin for Patients with Type-2 Diabetes: A Randomized Crossover Study by Flash Glucose MonitoringYuji Kawaguchi, Jun Sawa, Yasuro Kumeda
Clinical Calcium|March 19, 2005
[Renal osteodystrophy with diabetic bone disease]Yasuro Kumeda, Masaaki Inaba, Eiji Ishimura
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 15, 2002
[Diabetes mellitus and osteoporosis]Yasuro Kumeda, Masaaki Inaba, Yoshiki Nishizawa
Journal of Diabetes Investigation|June 28, 2018
Efficacy and safety of insulin glargine 300 U/mL vs insulin degludec in patients with type 2 diabetes: A randomized, open-label, cross-over study using continuous glucose monitoring profilesYuji Kawaguchi, Jun Sawa, Noriko Sakuma, et al.
Diabetology & Metabolic Syndrome|May 10, 2023
Beneficial effects of luseogliflozin on lipid profile and liver function in patients with type 2 diabetes mellitus (BLUE trial): a single-center, single-arm, open-label prospective studyYuriko Hajika, Yuji Kawaguchi, Kenji Hamazaki, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 23, 2019
Differential Effect of Hypoalbuminemia on Hypoglycemia on Type 2 Diabetes Patients Treated with Insulin Glargine 300 U/ml and Insulin DegludecYuji Kawaguchi, Jun Sawa, Chie Hamai, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Clinical Calcium|August 3, 2006
[Bone metabolic abnormality in diabetes: especially about osteoblast dysfunction]Yasuro Kumeda
Clinical Calcium|May 1, 2008
[Osteoporosis in diabetes]Yasuro Kumeda
Clinical Calcium|November 8, 2005
[Metabolic syndrome and magnesium]Yasuro Kumeda, Masaaki Inaba
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 1, 2002
[Diabetic osteoporosis]Yasuro Kumeda, Masaaki Inaba
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 16, 2020
Efficacy and Safety of Tofogliflozin and Ipragliflozin for Patients with Type-2 Diabetes: A Randomized Crossover Study by Flash Glucose MonitoringYuji Kawaguchi, Jun Sawa, Yasuro Kumeda
Clinical Calcium|March 19, 2005
[Renal osteodystrophy with diabetic bone disease]Yasuro Kumeda, Masaaki Inaba, Eiji Ishimura
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 15, 2002
[Diabetes mellitus and osteoporosis]Yasuro Kumeda, Masaaki Inaba, Yoshiki Nishizawa
Journal of Diabetes Investigation|June 28, 2018
Efficacy and safety of insulin glargine 300 U/mL vs insulin degludec in patients with type 2 diabetes: A randomized, open-label, cross-over study using continuous glucose monitoring profilesYuji Kawaguchi, Jun Sawa, Noriko Sakuma, et al.
Diabetology & Metabolic Syndrome|May 10, 2023
Beneficial effects of luseogliflozin on lipid profile and liver function in patients with type 2 diabetes mellitus (BLUE trial): a single-center, single-arm, open-label prospective studyYuriko Hajika, Yuji Kawaguchi, Kenji Hamazaki, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 23, 2019
Differential Effect of Hypoalbuminemia on Hypoglycemia on Type 2 Diabetes Patients Treated with Insulin Glargine 300 U/ml and Insulin DegludecYuji Kawaguchi, Jun Sawa, Chie Hamai, et al.
Pageof 5